Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengyan Xiang

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2021
Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic CancerAslamuzzaman Kazi, Liwei Chen, Shengyan Xiang, et al.
Cell Death & Disease|May 9, 2020
The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53Chen Hu, Mu Zhang, Niko Moses, et al.
The Journal of Biological Chemistry|October 4, 2013
Extracellular signal-regulated kinase (ERK) phosphorylates histone deacetylase 6 (HDAC6) at serine 1035 to stimulate cell migrationKendra A Williams, Mu Zhang, Shengyan Xiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic TumorsAslamuzzaman Kazi, Shengyan Xiang, Hua Yang, et al.
Scientific Reports|November 18, 2023
Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapyDarcy L Welch, Brooke L Fridley, Ling Cen, et al.
Molecular Cell|June 3, 2014
HDAC6 deacetylates and ubiquitinates MSH2 to maintain proper levels of MutSαMu Zhang, Shengyan Xiang, Heui-Yun Joo, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2021
Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic CancerAslamuzzaman Kazi, Liwei Chen, Shengyan Xiang, et al.
Cell Death & Disease|May 9, 2020
The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53Chen Hu, Mu Zhang, Niko Moses, et al.
The Journal of Biological Chemistry|October 4, 2013
Extracellular signal-regulated kinase (ERK) phosphorylates histone deacetylase 6 (HDAC6) at serine 1035 to stimulate cell migrationKendra A Williams, Mu Zhang, Shengyan Xiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic TumorsAslamuzzaman Kazi, Shengyan Xiang, Hua Yang, et al.
Scientific Reports|November 18, 2023
Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapyDarcy L Welch, Brooke L Fridley, Ling Cen, et al.
Molecular Cell|June 3, 2014
HDAC6 deacetylates and ubiquitinates MSH2 to maintain proper levels of MutSαMu Zhang, Shengyan Xiang, Heui-Yun Joo, et al.
Pageof 3